AMSilk
AMSilk produces 100% protein-based recombinant spider-silk yarns that reached consumer garments in 2026, and supplies lightweight biotech materials for aerospace and premium apparel.
- Country
- Germany
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| fibers-textiles | ✓ | ✓ | ✓ |
| genome-engineering | ✓ | ✓ | ✓ |
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpaepareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Recombinant spider silk & engineered protein fibers | fibers-textiles | Medium | → |
| Silk fibroin (recombinant, biomaterials) | specialty-fine-chem | Low | → |
| Synthetic biology | genome-engineering | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.